QuiVad

Home / France / Eurofins Scientific SE

Eurofins Scientific SE

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 9.60% on April 30, 2019. The shaded band is the year shown above.

November 1, 2012 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

409 disclosures on record for this share.
DateFund% of capitalEnd of publication
June 14, 2019Coltrane Master Fund, L.P.1.09%March 11, 2020
June 12, 2019Marshall Wace LLP0.60%May 26, 2020
June 11, 2019Blackrock Investment Management (UK) Limited0.95%August 19, 2020
June 11, 2019Citadel Europe LLP0.59%October 21, 2019
June 11, 2019Marshall Wace LLP0.59%May 26, 2020
June 10, 2019Odey Asset Management LLP0.85%November 22, 2019
June 10, 2019Blackrock Investment Management (UK) Limited0.79%August 19, 2020
June 7, 2019Blackrock Investment Management (UK) Limited0.69%August 19, 2020
June 7, 2019AQR Capital Management, LLC0.59%July 31, 2019
June 6, 2019Citadel Europe LLP0.60%October 21, 2019
June 5, 2019Coltrane Master Fund, L.P.1.14%March 11, 2020
June 5, 2019Marshall Wace LLP0.60%May 26, 2020
June 3, 2019Citadel Europe LLP0.53%October 21, 2019
May 17, 201953 House LLP0.60%August 24, 2020
May 15, 2019Odey Asset Management LLP0.90%November 22, 2019
May 15, 2019Citadel Europe LLP0.62%October 21, 2019
May 15, 2019Marshall Wace LLP0.50%May 26, 2020
May 14, 2019Citadel Europe LLP0.56%October 21, 2019
May 13, 2019Marshall Wace LLP0.49%May 15, 2019
May 8, 2019AQR Capital Management, LLC0.69%July 31, 2019
May 8, 2019Marshall Wace LLP0.50%May 15, 2019
May 3, 2019Marshall Wace LLP0.49%May 7, 2019
May 2, 2019Och-Ziff Management Europe Limited2.12%May 2, 2019
May 2, 2019Sculptor Capital Management Europe Limited2.12%February 3, 2021
April 30, 2019Och-Ziff Management Europe Limited2.04%still open
April 30, 2019Sculptor Capital Management Europe Limited2.04%February 3, 2021
April 29, 2019Och-Ziff Management Europe Limited1.92%still open
April 29, 2019Sculptor Capital Management Europe Limited1.92%February 3, 2021
April 26, 2019Och-Ziff Management Europe Limited1.79%still open
April 26, 2019Sculptor Capital Management Europe Limited1.79%February 3, 2021
April 25, 2019Blackrock Investment Management (UK) Limited0.70%August 19, 2020
April 16, 2019AQR Capital Management, LLC0.79%July 31, 2019
April 2, 2019Lansdowne Partners (UK) LLP0.49%April 4, 2019
April 1, 2019Blackrock Investment Management (UK) Limited0.60%August 19, 2020
March 29, 2019AQR Capital Management, LLC0.89%July 31, 2019
March 29, 2019Blackrock Investment Management (UK) Limited0.59%August 19, 2020
March 29, 201953 House LLP0.53%August 24, 2020
March 7, 2019AQR Capital Management, LLC0.99%July 31, 2019
March 7, 2019Blackrock Investment Management (UK) Limited0.60%August 19, 2020
March 6, 2019Blackrock Investment Management (UK) Limited0.59%August 19, 2020
March 4, 2019Och-Ziff Management Europe Limited1.66%still open
March 4, 2019Sculptor Capital Management Europe Limited1.66%February 3, 2021
March 1, 2019Och-Ziff Management Europe Limited1.53%still open
March 1, 2019Sculptor Capital Management Europe Limited1.53%February 3, 2021
February 25, 2019Marshall Wace LLP0.59%May 7, 2019
February 22, 2019Och-Ziff Management Europe Limited1.47%still open
February 22, 2019Sculptor Capital Management Europe Limited1.47%February 3, 2021
February 21, 2019Och-Ziff Management Europe Limited1.33%still open
February 21, 2019Sculptor Capital Management Europe Limited1.33%February 3, 2021
February 21, 2019Coltrane Master Fund, L.P.1.08%March 11, 2020

Other companies sold short in France

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Eurofins Scientific SE, source AMF, data as at August 4, 2026, https://www.quivad.com/action/eurofins-scientific-se?page=7